paeonol has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Ding, Y; Gong, W; Lu, G; Pan, J; Wang, N; Wu, K; Xiao, W; Xu, X; Yao, G; Yuan, C; Zhang, J; Zhu, Q | 1 |
| Na, G; Wang, J; Wang, X; Yin, X; Zhang, P; Ирина Павловна, К | 1 |
2 other study(ies) available for paeonol and Acute Disease
| Article | Year |
|---|---|
Paeonol protects against acute pancreatitis by inhibiting M1 macrophage polarization via the NLRP3 inflammasomes pathway.
Topics: Acetophenones; Acute Disease; Animals; Ceruletide; Inflammasomes; Macrophages; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Pancreatitis; Reactive Oxygen Species | 2022 |
Paeonol protects against acute pancreatitis by Nrf2 and NF-κB pathways in mice.
Topics: Acute Disease; Animals; Mice; NF-E2-Related Factor 2; NF-kappa B; Pancreatitis | 2022 |